Asthma is a chronic respiratory condition affecting over 339 million people worldwide. As urbanization increases and air quality remains a critical concern in industrial sectors, the demand for effective Asthma relief products has transitioned from niche medical supplies to a massive global retail and industrial necessity. Today, the asthma management market is worth billions, with a shift towards natural, rapid-acting, and non-invasive relief methods.
The respiratory health market is projected to grow by 6% CAGR through 2030, driven by an aging global population and rising environmental pollution.
Smart nebulizers and IoT-enabled monitoring devices are becoming standard in modern asthma management protocols.
Hybrid solutions combining traditional pharmaceutical APIs with herbal vapor rubs and soothing ointments are gaining consumer preference.
Modern consumers are seeking portable and discreet solutions. From electronic physiotherapy devices that utilize magnetic pulse therapy to essential oil-based vapor rubs, the industry is moving toward "anytime-anywhere" relief. As a China top wholesale asthma relief products manufacturer, Xian QLU Health Pharmaceutical stays ahead of these trends by integrating advanced delivery systems with time-tested formulas to ensure maximum bioavailability and patient comfort.
Local application scenarios include home care kits for seniors, portable kits for athletes with exercise-induced asthma, and industrial safety supplies for workers in high-dust environments like mining or construction.
China has solidified its position as the world's pharmacy, characterized by robust supply chains, advanced R&D centers, and cost-effective manufacturing without compromising on quality. As a primary Asthma Relief Products factory, our infrastructure allows us to serve the complex procurement needs of global distributors and healthcare providers.
International buyers are no longer just looking for the lowest price; they demand compliance with international standards (GMP, ISO, HALAL), scalability for mass orders, and customization (OEM/ODM) capabilities. We provide comprehensive solutions that meet the stringent regulatory requirements of markets in North America, Europe, and Southeast Asia.
Xian QLU Health Pharmaceutical Technology Co., Ltd. is a global leader engaged in the development, production, and marketing of pharmaceutical products, food ingredients, vitamins, intermediates, and high-purity chemicals.
Headquartered in historic Xian, China, we operate three state-of-the-art production bases in Shandong, Zhejiang, and Hebei. With decades of experience in the production of APIs and chemical products, our facilities are fully certified with GMP, ISO, FAMI-QS, KOSHER, and HALAL. We maintain absolute control over our product development, design, and manufacturing processes through advanced equipment and rigorous inspection protocols.
In the rapidly evolving pharmaceutical landscape, QLU is defined by flexibility and adaptability. We actively embrace AI-integrated manufacturing, adopt the latest scientific breakthroughs, and continuously evolve to meet the changing needs of patients and healthcare providers globally. Our Strategic Marketing Partners in Mumbai and Dubai ensure we remain a reliable partner for your procurement needs.
Established focus on pharmaceutical products, food ingredients, and essential vitamins.
Expanded marketing operations for APIs, ingredients, and chemical intermediates.
Fully integrated production for APIs and health ingredients across three Chinese bases.
Launched advanced developments in diverse pharmaceutical APIs and chemical synthesis.
QLU Health
